Clinical Trial Update: Study of BHV-1300 in Graves' Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating BHV-1300 for Graves' disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• BHV-1300

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Graves Disease | Phase 1 | Status: RECRUITING